FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/073463 [Registered on: 05/09/2024] Trial Registered Prospectively
Last Modified On: 29/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Single Arm Study 
Public Title of Study   Association of Financial Burden with Survival Status and Quality of Life of Cancer patients 
Scientific Title of Study   To evaluate the economic burden of cancer on cancer patients and society  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Rajneesh Singh 
Designation  Principal Investigator 
Affiliation  Banasthali Vidyapith 
Address  Department of Statistics Banasthali Vidyapith Vanasthali Rd, Aliyabad, Radha Kishnpura, Rajasthan 304022

Tonk
RAJASTHAN
304022
India 
Phone  8860215963  
Fax    
Email  Rajneeshyog@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. H. S Singh  
Designation  Physician  
Affiliation  Swami Harshankaranand Ji Hospital & Research Cente 
Address  Swami Harshankaranand Ji- Hospital & Research Center, Bhikaripur Crossing, Opposite Union Bank Of India, B.H.U Road

Varanasi
UTTAR PRADESH
221005
India 
Phone  8860215963  
Fax    
Email  inference.infinity@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Rajneesh Singh 
Designation  Principal Investigator 
Affiliation  Banasthali Vidyapith 
Address  Banasthali Vidyapith Department of Statistics Vanasthali Rd, Aliyabad, Radha Kishnpura, Rajasthan 304022

Tonk
RAJASTHAN
304022
India 
Phone  8860215963  
Fax    
Email  rajneeshyog@gmail.com  
 
Source of Monetary or Material Support  
Sankhya Incorpoartion 276, DSR Ridge, 6th Cross Rd, Domlur I Stage, 1st Stage, Domlur, Bengaluru, Karnataka, 560071 India 
 
Primary Sponsor  
Name  RAJNEESH SINGH 
Address  Domlur 2nd Stage Road. Building Name - MC House / 276 City- Bengaluru State - Karnataka Pin Code- 560071 Country - India  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
RAJNEESH  Charak Hospital  OPD- General Physician Ward. (Room No. 100) Jehangirabad, Old Nav Bharat Press Building , Bhopal - 462001 Madhya Pradesh
Bhopal
MADHYA PRADESH 
8860215963

rajneeshyog@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee – CHARAK HOPITAL ECR/1562/INST/MP/2021  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: D||Radiation Therapy,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patients can able to read the informed consent.
Having a ID Proof for the Age and other details.

 
 
ExclusionCriteria 
Details  No minor participants will be enrolled.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Assessment of Quality of Life of Cancer Patients   After - 3 months, 6 months and 12 months 
 
Secondary Outcome  
Outcome  TimePoints 
To find the association of financial stress and QoL  3, 6 and 12 months 
 
Target Sample Size   Total Sample Size="200"
Sample Size from India="200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   16/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="1"
Days="1" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   One important indicator of a cancer diagnosis is quality of life (QoL). The length of the therapy, the severity of the condition, and the cost of the new medication are some of the variables that affect the direct and indirect costs of cancer care. As a result, this study presents the relationship between financial expenses and quality of life in cancer patients.  
Close